ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.

Rafael Duran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.